Abstract
Antibiotic resistance represents a critical global health threat, with conventional antimicrobial treatments losing efficacy against multidrug-resistant (MDR) pathogens. Nanomaterials offer a transformative avenue for tackling this challenge by leveraging their unique physicochemical properties to enhance antimicrobial action, prevent biofilm formation, and serve as carriers for targeted drug delivery. This article reviews the multifaceted role of nanomaterials in preventing antibiotic resistance through direct antibacterial effects, synergistic drug-nanoparticle combinations, and disruption of resistance mechanisms. The potential of metal-based, polymeric, carbon-based, and hybrid nanomaterials is discussed, along with the challenges in clinical translation. Ultimately, nanotechnology holds promise in reshaping the fight against antimicrobial resistance (AMR) and restoring the efficacy of antibacterial therapies.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Dr. Martina Feldstein (Author)